Johnson & Johnson named Tom Cavanaugh to lead Innovative Medicine as Jennifer Taubert retires after more than 21 years with J ...

Two newly published papers underscore the need for increased awareness, caregiver education, and preparedness to help ensure timely use of epinephrine during severe allergic reactions ...

There's a change at the helm of Johnson & Johnson's pharma division in the offing, as executive vice president Jennifer ...

Keytruda made Merck an oncology powerhouse, but as the patent cliff looms, its business development leader outlines what’s ...

LOTTE Holdings Co., Ltd. (Tokyo, Japan; CEO: Genichi Tamatsuka, hereinafter “LOTTE Holdings”) announces an investment in Metaphore Biotechnologies, Inc. (Headquarters: Cambridge, MA, USA; CEO: Angela ...

A massive analysis of immune cells in human tissue is yielding clues to the root causes of lung and autoimmune diseases.

Tonix Pharmaceuticals Holding Corp. (Nasdaq: TNXP) (“Tonix” or the “Company”), a fully integrated, commercial-stage ...

BROADEN2 Phase 2b AD trial nearly six months ahead of anticipated timeline, with data expected by year-end 2026 ...

Proposition 38 is far from the most high-profile measure that will face California voters in November. But in a year where ...

AbbVie Inc. stock fell 6.2% after a 52-week high despite strong Q2 earnings; Rinvoq and Elahere sales surged. Click for this ...

AbbVie Inc. reported second quarter profit and sales that topped Wall Street’s expectations, driven by strong demand across ...

Johnson & Johnson also gains an exclusive option to acquire Sail Biosciences for $2.58 billion. The deal puts J&J in the mix ...